Newsletters
Read the Blog
Drug-Drug Interactions - What you Should Know
Drugs are a critical part of the prevention and treatment of diseases. While drug treatments are necessary for their positive impact on the quality of patients’ lives, the increasing number of drugs available on the market means a greater potential for drug-drug interactions (DDIs).
NEWSLETTERS
-
Newsletter
January 2018
GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing
-
Newsletter
June 2017
Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.
-
Newsletter
February 2017
Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!
-
Newsletter
December 2016
On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.
-
Newsletter
November 2016
On November 10th, the European Medicines Agency followed through on plans to update its guidance on first-in-human clinical trials.
-
Newsletter
October 2016
For everything you need to know about our alternative solution to assess transdermal patch adhesion, our interactive timeline planning tool, and so much more!
-
Newsletter
September 2016
Download our guide to NDA Filing Studies and learn more about our secret to on-time participant recruitment and retention.